Douglas Laboratories obtains exclusive distribution rights of Corvalen D-Ribose

February 28, 2011 — Douglas Laboratories recently announced that Bioenergy Life Science Inc. has granted it exclusive North America distribution rights of Corvalen D-Ribose, a nutritional supplement formulated and clinically shown to help restore depleted energy reserves.

“We are proud to add Corvalen D-Ribose to our line of nutraceutical products, enhancing our promise to provide the best and latest supplements on the market,” said Doug Lioon, Executive Chairman. “Ribose is a highly sought after supplement among consumers due to its enhancing effect on their energy levels. And now, this product is only available to healthcare practitioners exclusively through Douglas Laboratories.”

Ribose is used by the body to regulate synthesis of adenosine triphosphate (ATP), which is the energy currency of cells. Corvalen contains a patented formulation of pure Bioenergy Ribose, a safe and clinically proven ingredient designed to accelerate the natural way the human body produces energy.

“Corvalen (ribose) has appropriately been called The Sugar of Life,” said Dr. Jacob Teitelbaum, MD. “It is the most exciting new nutrient discovery of this decade.”  Corvalen D-Ribose supplementation has been clinically shown to support heart health and reduce fatigue, muscle soreness and stiffness associated with reduced cellular energy.*

It is said to have been clinically proven to restore cellular energy needed to promote healthy tissue function, increase exercise tolerance and improve quality of life.  *This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Source: Douglas Laboratories, www.douglaslabs.com